← Scroll for more →
Financial Statements — CHR
Balance Sheet
(in millions USD)| Metric | Q4 2025 | Q2 2025 | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 | Q4 2022 | Q4 2021 | Q2 2021 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 242.08 | 203.23 | 197.66 | 186.09 | 194.53 | 152.44 | -- | 77.30 | 20.31 |
| Short-term Investments | -- | -- | -- | -- | -- | -- | -- | -- | 1.73 |
| Accounts Receivable | 79.68 | 86.24 | 77.07 | 79.82 | 81.17 | 67.16 | 98.03 | 63.14 | 115.75 |
| Total Current Assets | 366.59 | 323.54 | 305.57 | 314.00 | 306.87 | 246.98 | 183.85 | 153.54 | 161.45 |
| Property, Plant & Equipment | 0.02 | 0.02 | 0.03 | 0.05 | 0.09 | 0.12 | 0.16 | 0.24 | 0.27 |
| Intangible Assets | 34.73 | 38.78 | 40.53 | 18.18 | 20.26 | 18.03 | 20.30 | 16.72 | 14.84 |
| Total Non-current Assets | 35.11 | 39.21 | 41.02 | 19.24 | 20.76 | 19.33 | 22.12 | 41.63 | 43.87 |
| Total Assets | 401.69 | 362.75 | 346.59 | 333.24 | 327.63 | 266.30 | 205.96 | 195.17 | 205.32 |
| Accounts Payable | 2.74 | 1.48 | 2.04 | 2.67 | 9.60 | 4.99 | 6.41 | 12.88 | 36.75 |
| Short-term Debt | 7.65 | 7.58 | 0.01 | -- | -- | -- | -- | -- | -- |
| Total Current Liabilities | 31.79 | 39.04 | 39.90 | 45.48 | 46.22 | 33.25 | 32.90 | 34.56 | 64.56 |
| Long-term Debt | -- | -- | -- | -- | 1.41 | -- | -- | -- | -- |
| Total Non-current Liabilities | 0.13 | 1.52 | 1.62 | 1.62 | 1.41 | 0.20 | 0.56 | 1.15 | 3.19 |
| Total Liabilities | 31.92 | 40.56 | 41.52 | 47.09 | 47.63 | 33.45 | 33.46 | 35.71 | 67.75 |
| Retained Earnings | 232.75 | 214.88 | 207.13 | 193.58 | 181.16 | 159.43 | 150.69 | 123.98 | 105.79 |
| Total Stockholder Equity | 369.68 | 322.11 | 304.99 | 286.07 | 279.93 | 232.78 | 172.43 | 158.91 | 137.15 |
← Scroll for more columns →
Income Statement
(in millions USD) (except per-share rows)| Metric | Q2 2025 | Q2 2024 | Q2 2023 | Q2 2021 |
|---|---|---|---|---|
| Total Revenue | 70.99 | 71.06 | 67.44 | 71.90 |
| Cost of Revenue* | 20.77 | 18.89 | 16.95 | -- |
| Gross Profit | 50.22 | 52.17 | 50.49 | -- |
| Research & Development | 2.33 | 1.36 | 0.64 | 0.34 |
| Selling, General & Admin | 4.24 | 1.61 | 2.27 | 2.32 |
| Total Operating Expenses* | (59.24) | 40.53 | 58.72 | 55.68 |
| Operating Income | 8.32 | 11.64 | 8.71 | 16.21 |
| Interest Expense | -- | -- | (0.03) | 0.24 |
| Pretax Income | 7.75 | 11.84 | 8.84 | 16.95 |
| Tax Provision | -0.00 | (0.58) | 0.04 | 0.03 |
| Net Income | 7.76 | 12.42 | 8.75 | 16.92 |
| Basic EPS | 0.67 | 1.23 | 0.12 | 0.27 |
| Diluted EPS | 0.67 | 1.23 | 0.12 | 0.27 |
← Scroll for more columns →
* Derived from reported values
Cash Flow Statement
(in millions USD)| Metric | Q2 2025 | Q2 2024 | Q2 2023 | Q2 2021 |
|---|---|---|---|---|
| Operating Cash Flow | 3.92 | (6.74) | 27.18 | (11.89) |
| Capital Expenditures | -- | 0.00 | -- | -- |
| Free Cash Flow* | -- | (6.74) | -- | -- |
| Investing Cash Flow | -- | -- | (0.06) | 1.68 |
| Financing Cash Flow | (2.12) | 2.97 | 60.01 | 12.53 |
← Scroll for more columns →
* Derived from reported values